Michael F. Mahoney - 06 Sep 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Chairman, President & CEO, Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
06 Sep 2022
Net transactions value
-$3,918,286
Form type
4
Filing time
07 Sep 2022, 16:32:25 UTC
Previous filing
09 Aug 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Gift $0 -365,457 -17% $0.000000 1,767,665 30 Aug 2022 Direct F1
transaction BSX Common Stock Options Exercise $610,170 +82,567 +4.7% $7.39* 1,850,232 06 Sep 2022 Direct F2
transaction BSX Common Stock Options Exercise $565,854 +43,261 +2.3% $13.08 1,893,493 06 Sep 2022 Direct F2
transaction BSX Common Stock Sale $5,094,310 -125,828 -6.6% $40.49 1,767,665 06 Sep 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -43,261 -14% $0.000000 259,561 06 Sep 2022 Common Stock 43,261 $13.08 Direct F2, F4
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -82,567 -33% $0.000000 165,134 06 Sep 2022 Common Stock 82,567 $7.39 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a gift of securities by the reporting person to the Michael F. Mahoney 2 Year Qualified Annuity Trust - 2022, which is administered by an independent trustee.
F2 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F3 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.23 to $40.69, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
F5 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.